Global Ganja Report

Alabama's Gov. Kay Ivey signed a bill May 17 legalizing the use of medical cannabis products in the state—on strictly limited terms. The new law, coming after decades of Republican opposition, allows use of extracts, tinctures, tablets or gel cubes—but not herbaceous flower, or any other products that can be smoked or vaped. Edibles such as cookies or candies are also barred.

As political and legal space opens for cannabis in state after state, the idea of caps on the potency — whether of flower, extracts or edibles — is gaining currency. But voices in the cannabis industry view this as a phobic response rooted in the flawed assumptions of prohibition.

Among the ambiguous areas in the state medical marijuana laws from coast to coast is the status of cannabis and its derivatives as veterinary medications. Now, a new non-profit has been launched to advocate for legal standards and clarity on the question.

Even as the edifice of cannabis prohibition crumbles state by state, the federal illegality of the plant and its psychoactive compound THC continues to drive a quest for loopholes in the relevant statutes.


The latest such legal artifice concerns Delta-8 tetrahydrocannabinol — a less potent cannabinoid than the more common and notorious Delta-9 THC. Is there truth to the claim that hemp-derived Delta-8 THC was inadvertently legalized by the 2018 Farm Bill?

After years of activist effort, New York state finally passed the Marijuana Regulation & Taxation Act (MRTA), signed into law by a politically besieged Gov. Andrew Cuomo. This is being hailed as a victory by advocates, who pledge to craft a model of legalization that will dismantle a long legacy of racism and oppression under the prohibition regime.

After a frustrating delay and deadlock in the statehouse, New Jersey finally answered the will of the voters in last year's referendum, and passed enabling legislation to create a regulated adult-use cannabis market. Activists are still dissatisfied with limits—most significantly, no provision for homegrown—and have concerns about how a "recreational" market will impact medical users. But the belated move is being hailed as a victory that ups the pressure on neighboring New York to follow through on pledges to legalize—and even on the federal government.

At the annual Vienna meeting of the Commission on Narcotic Drugs, the governing body of the UN Office on Drugs & Crime (UNODC) voted Dec. 2 to strike cannabis from Schedule IV of the 1961 Single Convention on Narcotic Drugs, the global treaty regulating drug control policy.

A new day has dawned for medical marijuana patients in Argentina, who have finally won the right to home cultivation, three and a half years after medicinal use of cannabis derivatives was officially legalized in the South American country.

President Alberto Fernández on Nov. 12 signed a decree that had been issued by the Health Ministry earlier this year, stating: "It is imperative to create a regulatory framework that allows timely, inclusive and secure access for those who require to use cannabis as a therapeutic tool."